Basic Information
| RNALocate ID: | RLID:01001363 |
| RNA Symbol: | hsa-miR-27a-3p |
| Localization: | Mitochondrion |
RNA Information
| RNA Name: | hsa-miR-27a |
| RNA ID: | miRBase:MIMAT0000084 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 21637849 |
| Tissue/Cell Line: | Skeletal muscle myoblasts |
| Method: | ISH|qRT-PCR |
| Description: | List of microRNA significantly detected in the mitochondrial mRNA at three increasing mtRNA inputs (1, 5 and 35 uL). Table S3 List of microRNA significantly detected (Cp<35) in the mitochondrial mRNA at the two highest mtRNA inputs (5 and 35 uL). Data are collected from Table 4 and S3. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001361 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001362 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001364 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001365 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001366 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11000872 | Exosome | Cell lines (MCF10A|MCF-7|MDA-MB-231) | 25446899 |
| RLID:11000873 | Exosome | Glioblastoma cells | 19011622 |
| RLID:11000874 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11000875 | Exosome | B cell line (Raji)|Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000876 | Exosome | Breast milk | 22211110 |
| RLID:11000877 | Exosome | Brain tissue | 23382797 |
| RLID:11000878 | Exosome | Plasma | 23663360 |
| RLID:11000879 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11000880 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11000881 | Microvesicle | Glioblastoma cells | 19011622 |
| RLID:11000882 | Microvesicle | Plasma | 23077538 |
| RLID:11000883 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11000884 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000020 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000283 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-27a-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-33556 |
| MNDR | hsa-miR-27a-3p | Oral squamous cell carcinoma | MNDR-E-MI-33557 |
| MNDR | hsa-miR-27a-3p | Medulloblastoma | MNDR-E-MI-33558 |
| MNDR | hsa-miR-27a-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-33559 |
| MNDR | hsa-miR-27a-3p | Lymphoma | MNDR-E-MI-33560 |
| MNDR | hsa-miR-27a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-33561 |
| MNDR | hsa-miR-27a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-33562 |
| MNDR | hsa-miR-27a-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-33563 |
| MNDR | hsa-miR-27a-3p | Dermatomyositis | MNDR-E-MI-33564 |
| MNDR | hsa-miR-27a-3p | Prostate cancer | MNDR-E-MI-33565 |
| MNDR | hsa-miR-27a-3p | Gastric cancer | MNDR-E-MI-33566 |
| MNDR | hsa-miR-27a-3p | Pre-eclampsia | MNDR-E-MI-33567 |
| MNDR | hsa-miR-27a-3p | Alzheimer disease | MNDR-E-MI-33568 |
| MNDR | hsa-miR-27a-3p | Hand foot and mouth disease | MNDR-E-MI-33569 |
| MNDR | hsa-miR-27a-3p | Urinary bladder cancer | MNDR-E-MI-33570 |
| MNDR | hsa-miR-27a-3p | Esophageal carcinoma | MNDR-E-MI-33571 |
| MNDR | hsa-miR-27a-3p | Sarcoma | MNDR-E-MI-33572 |
| MNDR | hsa-miR-27a-3p | Osteoporosis | MNDR-E-MI-33573 |
| MNDR | hsa-miR-27a-3p | Dysautonomia familial | MNDR-E-MI-33574 |
| MNDR | hsa-miR-27a-3p | Myotonic dystrophy | MNDR-E-MI-33575 |
| MNDR | hsa-miR-27a-3p | Head and neck cancer | MNDR-E-MI-33576 |
| MNDR | hsa-miR-27a-3p | Alcoholic hepatitis | MNDR-E-MI-33577 |
| MNDR | hsa-miR-27a-3p | Leukemia | MNDR-E-MI-33578 |
| MNDR | hsa-miR-27a-3p | Hereditary hemorrhagic telangiectasia | MNDR-E-MI-33579 |
| MNDR | hsa-miR-27a-3p | Cardiovascular disease | MNDR-E-MI-33580 |
| MNDR | hsa-miR-27a-3p | Carotid stenosis | MNDR-E-MI-33581 |
| MNDR | hsa-miR-27a-3p | Uterine fibroid | MNDR-E-MI-33582 |
| MNDR | hsa-miR-27a-3p | Lung cancer | MNDR-E-MI-33583 |
| MNDR | hsa-miR-27a-3p | Down syndrome | MNDR-E-MI-33584 |
| MNDR | hsa-miR-27a-3p | Fragile x syndrome | MNDR-E-MI-33585 |
| MNDR | hsa-miR-27a-3p | Parkinson disease | MNDR-E-MI-33586 |
| MNDR | hsa-miR-27a-3p | Machado-joseph disease | MNDR-E-MI-33587 |
| MNDR | hsa-miR-27a-3p | Breast cancer | MNDR-E-MI-33588 |
| MNDR | hsa-miR-27a-3p | Squamous cell carcinoma | MNDR-E-MI-33589 |
| MNDR | hsa-miR-27a-3p | Pancreatic cancer | MNDR-E-MI-33590 |
| MNDR | hsa-miR-27a-3p | Melanoma | MNDR-E-MI-33591 |
| MNDR | hsa-miR-27a-3p | Rectum adenocarcinoma | MNDR-E-MI-33592 |
| MNDR | hsa-miR-27a-3p | Nephroblastoma | MNDR-E-MI-33593 |
| MNDR | hsa-miR-27a-3p | Colon cancer | MNDR-E-MI-33594 |
| MNDR | hsa-miR-27a-3p | Colon adenocarcinoma | MNDR-E-MI-33595 |
| MNDR | hsa-miR-27a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-33596 |
| MNDR | hsa-miR-27a-3p | Ovarian cancer | MNDR-E-MI-33597 |
| MNDR | hsa-miR-27a-3p | Prostate adenocarcinoma | MNDR-E-MI-33598 |
| MNDR | hsa-miR-27a-3p | Kidney cancer | MNDR-E-MI-33599 |
| MNDR | hsa-miR-27a-3p | Carcinoma ductal breast | MNDR-E-MI-33600 |
| MNDR | hsa-miR-27a-3p | Glioblastoma | MNDR-E-MI-33601 |
| MNDR | hsa-miR-27a-3p | Astrocytoma | MNDR-E-MI-33602 |
| MNDR | hsa-miR-27a-3p | Glioma | MNDR-E-MI-33603 |
| MNDR | hsa-miR-27a-3p | Chronic obstructive pulmonary disease | MNDR-E-MI-33604 |
| MNDR | hsa-miR-27a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-33605 |
| MNDR | hsa-miR-27a-3p | Epilepsy temporal lobe | MNDR-E-MI-33606 |
| MNDR | hsa-miR-27a-3p | Osteosarcoma | MNDR-E-MI-33607 |
| MNDR | hsa-miR-27a-3p | Liposarcoma | MNDR-E-MI-33608 |
| MNDR | hsa-miR-27a-3p | Inclusion body myositis | MNDR-E-MI-33609 |
| MNDR | hsa-miR-27a-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-33610 |
| MNDR | hsa-miR-27a-3p | Meningioma | MNDR-E-MI-33611 |
| MNDR | hsa-miR-27a-3p | Liver cancer | MNDR-E-MI-33612 |
| MNDR | hsa-miR-27a-3p | Uterine cancer | MNDR-E-MI-33613 |
| MNDR | hsa-miR-27a-3p | Cervical adenocarcinoma | MNDR-E-MI-33614 |
| MNDR | hsa-miR-27a-3p | Gastric adenocarcinoma | MNDR-E-MI-33615 |
| MNDR | hsa-miR-27a-3p | Cervical squamous cell carcinoma | MNDR-E-MI-33616 |
| MNDR | hsa-miR-27a-3p | Lung squamous cell carcinoma | MNDR-E-MI-33617 |
| MNDR | hsa-miR-27a-3p | Carcinoma lung non-small-cell | MNDR-E-MI-33618 |
| MNDR | hsa-miR-27a-3p | Lung adenocarcinoma | MNDR-E-MI-33619 |
| MNDR | hsa-miR-27a-3p | Ovarian carcinoma | MNDR-E-MI-33620 |
| MNDR | hsa-miR-27a-3p | Bladder urothelial carcinoma | MNDR-E-MI-33621 |
| MNDR | hsa-miR-27a-3p | Pancreatic adenocarcinoma | MNDR-E-MI-33622 |
| MNDR | hsa-miR-27a-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-33623 |
| MNDR | hsa-miR-27a-3p | Carcinoma renal cell | MNDR-E-MI-33624 |
| MNDR | hsa-miR-27a-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-33625 |
| MNDR | hsa-miR-27a-3p | Clear cell renal cell carcinoma | MNDR-E-MI-33626 |
| MNDR | hsa-miR-27a-3p | Biliary tract cancer | MNDR-E-MI-33627 |
| MNDR | hsa-miR-27a-3p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-33628 |
| MNDR | hsa-miR-27a-3p | Cholangiocarcinoma | MNDR-E-MI-33629 |
| MNDR | hsa-miR-27a-3p | Esophageal cancer | MNDR-E-MI-33630 |
| MNDR | hsa-miR-27a-3p | Liver cirrhosis | MNDR-E-MI-33631 |
| MNDR | hsa-miR-27a-3p | Small cell lung cancer | MNDR-E-MI-33632 |
| MNDR | hsa-miR-27a-3p | Stomach carcinoma | MNDR-E-MI-33633 |
| MNDR | hsa-miR-27a-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-33634 |
| MNDR | hsa-miR-27a-3p | T acute lymphoblastic leukemia | MNDR-E-MI-33635 |
| MNDR | hsa-miR-27a-3p | Acute t cell leukemia | MNDR-E-MI-33636 |
| MNDR | hsa-miR-27a-3p | Acute heart failure | MNDR-E-MI-33637 |
| MNDR | hsa-miR-27a-3p | Encephalomyelitis | MNDR-E-MI-33638 |
| MNDR | hsa-miR-27a-3p | Breast invasive carcinoma | MNDR-E-MI-33639 |
| MNDR | hsa-miR-27a-3p | Early hepatocellular carcinoma | MNDR-E-MI-33640 |
| MNDR | hsa-miR-27a-3p | Lymphoblastoid | MNDR-E-MI-33641 |
| MNDR | hsa-miR-27a-3p | Rheumatoid arthritis | MNDR-E-MI-33642 |
| MNDR | hsa-miR-27a-3p | Retinoblastoma | MNDR-E-MI-33643 |
| MNDR | hsa-miR-27a-3p | Neuroblastoma | MNDR-E-MI-33644 |
| MNDR | hsa-miR-27a-3p | Hodgkin lymphoma | MNDR-E-MI-33645 |
| MNDR | hsa-miR-27a-3p | Burkitt lymphoma | MNDR-E-MI-33646 |
| MNDR | hsa-miR-27a-3p | Acute myelogenous leukemia | MNDR-E-MI-33647 |
| MNDR | hsa-miR-27a-3p | Colorectal cancer | MNDR-E-MI-33648 |
| MNDR | hsa-miR-27a-3p | Nasopharyngeal carcinoma | MNDR-E-MI-33649 |
| MNDR | hsa-miR-27a-3p | Nasopharynx carcinoma | MNDR-E-MI-33650 |
| MNDR | hsa-miR-27a-3p | Diabetes mellitus | MNDR-E-MI-33651 |
| MNDR | hsa-miR-27a-3p | Type 2 diabetes mellitus | MNDR-E-MI-33652 |
| MNDR | hsa-miR-27a-3p | Multiple myeloma | MNDR-E-MI-33653 |
| MNDR | hsa-miR-27a-3p | Esophageal squamous cell carcinoma | MNDR-E-MI-33654 |
| MNDR | hsa-miR-27a-3p | Ependymoma | MNDR-E-MI-33655 |
| MNDR | hsa-miR-27a-3p | Cardiomegaly | MNDR-E-MI-33656 |
| MNDR | hsa-miR-27a-3p | Nasopharyngeal cancer | MNDR-E-MI-33657 |
| MNDR | hsa-miR-27a-3p | Prostatic neoplasms | MNDR-E-MI-33658 |
| MNDR | hsa-miR-27a-3p | Pseudorabies | MNDR-E-MI-33659 |
| MNDR | hsa-miR-27a-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-33660 |
| MNDR | hsa-miR-27a-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-33661 |
| MNDR | hsa-miR-27a-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-33662 |
| MNDR | hsa-miR-27a-3p | Sarcopenia | MNDR-E-MI-33663 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCA1 | Homo sapiens | RR00022109 |
TOP